These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2852845)

  • 1. Increased susceptibility of periodate-treated tumour cells to human but not to mouse or rat natural killer cells.
    Axberg I
    Scand J Immunol; 1988 Dec; 28(6):697-704. PubMed ID: 2852845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target cell membrane modification and susceptibility to lymphokine-activated killer cell-mediated lysis. II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells.
    Midis GP; Gupta VK; Fabian DF; Lefor AT
    J Surg Res; 1994 Feb; 56(2):146-54. PubMed ID: 8121171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
    Wright SC; Wilbur SM; Bonavida B
    Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU; Golub SH
    J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of the in vitro established rat large granular lymphocyte leukaemia RNK-16.
    Axberg I; Nose M; Reynolds CW; Wigzell H
    Scand J Immunol; 1988 Mar; 27(3):271-8. PubMed ID: 3353687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.
    Une C; Grönberg A; Axberg I; Jondal M; Orn A
    Cell Immunol; 1991 Mar; 133(1):127-37. PubMed ID: 1703925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased natural killer (NK) susceptibility of human NK target cells after phosphatidylinositol-specific phospholipase C treatment.
    Uggla C; Une C; Axberg I; Jondal M; Knowles RW; Orn A
    Scand J Immunol; 1989 Jan; 29(1):83-9. PubMed ID: 2537997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.
    Giuliani-Bonmassar A; Graziani G; Frati L; Bonmassar E
    Int J Tissue React; 1984; 6(1):35-41. PubMed ID: 6585352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol.
    Baral E; Nagy E; Berczi I
    Cancer; 1995 Jan; 75(2):591-9. PubMed ID: 7812928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
    Laskay T; Kiessling R
    Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of natural killer susceptibility by indole alkaloid tumor promoter dihydroteleocidin B.
    Kabelitz D
    Cell Immunol; 1984 Aug; 87(1):304-8. PubMed ID: 6378393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-induced increase in neuraminidase-releasable sialic acid and glycosphingolipid metabolism in mouse lymphoma and L1210 leukemic cell lines: correlation with susceptibility to natural killer cell-mediated lysis.
    Yogeeswaran G; Grönberg A; Welsh RM; Kiessling R
    Int J Cancer; 1983 Apr; 31(4):501-7. PubMed ID: 6832856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of K562 cells with sodium butyrate. Association of impaired NK susceptibility with sialic acid and analysis of other parameters.
    Werkmeister JA; Pross HF; Roder JC
    Int J Cancer; 1983 Jul; 32(1):71-8. PubMed ID: 6862694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.